ProSciento’s drug compounding procedures strictly adhere to USP 797 thus ensuring the safety of clinical study participants and supporting the successful execution of clinical trials. ProSciento’s Clinical Research Unit (CRU) in Southern California has a state-of-the-art USP 797/800 clean room (positive/negative pressure/ante room), 24/7 storage temperature monitoring and alarm system, and secure, controlled access drug rooms.
